Tectonic Therapeutic (TECX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Tectonic Therapeutic (TECX) is Neutral.

The composite score behind that read is -0.13, weighing +0.32 of bullish evidence against -0.26 bearish.

Tectonic Therapeutic last closed at $22.41, -3.03% on the session.

Against the IVW growth benchmark the position is -3.64% over the forecast window.

The read is built from 12 underlying insights — 3 bullish and 9 bearish.

Agreement across those insights is 75%.

12 graded predictions for TECX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Tectonic Therapeutic in the 22nd percentile on return on equity, where 100 is best.

Tectonic Therapeutic is classified under Health Care / Biotechnology, with a market capitalisation of $451.78M.

StockMap tracks Tectonic Therapeutic as the 183rd largest of the 365 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 190 Moderate Underperform, 164 Neutral and 11 Strong Underperform.

On that composite Tectonic Therapeutic ranks 106th of 365 in the group, against a group median of -0.21.